Journal articlePediatr Dent · July 15, 2021
Purpose: The purpose of this study was to assess the relationship between the number of teeth present at 12 months and decayed, missing, or filled surfaces (dmfs) at 30 and 48 months. Methods: Data are from a longitudinal, multisite study with clinical den ...
Link to itemCite
Journal articleJ Pediatric Infect Dis Soc · February 19, 2018
This study compares the safety and immunogenicity of pentavalent rotavirus vaccine (RV5) administered on an alternative schedule (initiated at 2-5 weeks of age) with those of RV5 administered on the recommended standard schedule. Our findings support the f ...
Full textLink to itemCite
Journal articleAm J Clin Nutr · March 2017
Background: India's high prevalence of iron-deficiency anemia has largely been attributed to the local diet consisting of nonheme iron, which has lower absorption than that of heme iron.Objective: We assessed the efficacy of the consumption of iron-supplem ...
Full textLink to itemCite
Journal articleN C Med J · 2016
Vaccines stimulate the immune system, mimicking infectious attacks and thereby promoting the development of protective antibodies and/or cellular immunity so that the body is immune to infection when live native infections attack. Some of these infections ...
Full textLink to itemCite
Journal articleAppetite · February 2014
Evidence suggests that exposure to advertising of unhealthy foods may contribute to increased rates of obesity in children. This study examined the extent to which television stations marketed unhealthy foods to children during after-school programming air ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · August 2008
A second dose of varicella vaccine is routinely recommended. We report 2 cases of large local reactions after receipt of a second dose of varicella vaccine administered in the thigh. The reactions resolved with symptomatic therapy. Clinicians should contin ...
Full textLink to itemCite
Journal articleClin Infect Dis · May 1, 2004
The Burkholderia cepacia complex includes 9 genomovars. The relative virulence of each is unknown. Host and pathogen features associated with mortality were evaluated among patients with B. cepacia complex bacteremia. Cases were ascertained through review ...
Full textLink to itemCite
Journal articleAnn Intern Med · August 20, 2002
Featured Publication
BACKGROUND: Physicians have several treatment options for influenza, including vaccination and various antiviral therapies. However, the optimal influenza prevention and treatment strategy is unknown. OBJECTIVE: To compare the relative health values of con ...
Full textLink to itemCite
Journal articleArch Pediatr Adolesc Med · April 2001
Featured Publication
BACKGROUND: The increasing use of varicella vaccine in children attending day care has rapidly decreased the incidence of wild-type varicella disease. The herd immunity noted is significant and will have an effect on the epidemiology of natural varicella. ...
Full textLink to itemCite
Journal articleBioDrugs · July 2000
Varicella vaccines have been developed, studied, tested and used since the early 1970s, first in Japan and subsequently in Europe, the US, Asia and South and Central America. Varicella vaccination was first used to immunise Japanese children in cancer remi ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · December 1999
BACKGROUND: Varicella vaccine has been licensed for use in the United States since the spring of 1995. The acceptance of the vaccine and its effect on varicella incidence in children is important. AIM: To document the effectiveness of the varicella vaccine ...
Full textLink to itemCite
Journal articleJ Infect Dis · December 1999
A randomized trial comparing 3 manufacturing consistency lots of a combination hepatitis A/hepatitis B vaccine to each other and to hepatitis A vaccine and hepatitis B vaccine given separately and concurrently was done to evaluate safety, tolerability, and ...
Full textLink to itemCite
Journal articleVaccine · March 17, 1999
Featured Publication
301 healthy adult volunteers were randomized to one of three treatment groups: inactivated hepatitis A vaccine alone; inactivated hepatitis A vaccine with immune globulin (Ig) concurrently; or Ig alone. The first two treatment groups received a second dose ...
Full textLink to itemCite
Journal articleInfect Dis Clin North Am · September 1996
After incidental exposure to natural varicella, up to 18% of vaccinees reported a breakthrough infection known as modified varicella-like syndrome (MVLS) over up to 10 years of postvaccination follow-up, compared with natural varicella occurring in similar ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · January 1996
OBJECTIVE: To compare the safety and immunogenicity of a one- vs. two-dose regimen of Oka/Merck varicella vaccine in approximately 2000 healthy children 12 months to 12 years of age. METHODOLOGY: Subjects with a negative history of varicella were randomize ...
Full textLink to itemCite
Journal articleJ Paediatr Child Health · December 1995
Featured Publication
OBJECTIVE: To determine whether day-care attendance was a risk factor for Haemophilus influenzae type b (Hib) disease, particularly for epiglottitis. METHODOLOGY: A case-control analysis of risk factors for invasive Hib disease was performed in Victoria, A ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · October 1995
Featured Publication
A total of 465 healthy infants and adolescents ages 12 months to 17 years without a known history of varicella or recent exposure to varicella-zoster virus VZV were immunized with live attenuated Oka/Merck varicella vaccine from November, 1984, through Apr ...
Full textLink to itemCite
Journal articleArch Pediatr Adolesc Med · October 1995
Featured Publication
OBJECTIVE: To determine if the use of influenza vaccine in children in day care decreases the incidence of otitis media during the influenza season. DESIGN: Prospective cohort study. SETTING: Eight day-care centers in North Carolina. PARTICIPANTS: One hund ...
Full textLink to itemCite
Journal articleVaccine · August 1995
A multicenter clinical trial was conducted among 757 healthy adolescents and adults, 13-54 years, to compare two regimens of Oka/Merck varicella vaccine with respect to safety, tolerability, and immunogenicity. Participants were randomized to receive two i ...
Full textLink to itemCite
Journal articleJ Infect Dis · July 1995
Four hundred nineteen children and adolescents immunized with live varicella vaccine 4-6 years earlier were enrolled in a study to evaluate the safety and immune response to a booster dose containing approximately 3300 pfu of virus. Of the subjects, 99% (4 ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · May 1995
In order to provide the opportunity for women delivering newborns to have human immunodeficiency virus (HIV) testing we piloted a hospital-based voluntary HIV testing program during the newborn period using the Guthrie card. During the study period 789 wom ...
Full textLink to itemCite
Journal articleJ Paediatr Child Health · April 1995
OBJECTIVE: To document clinical manifestations, laboratory findings and outcome of childhood Haemophilus influenzae type b (Hib) infections. METHODOLOGY: Medical records of 235 children with Hib disease admitted to hospital during a 2 year period were revi ...
Full textLink to itemCite
Journal articlePharmacoeconomics · November 1994
On the basis of immunogenicity and protective efficacy studies, 4 Haemophilus influenzae type b (Hib) conjugate vaccines have been licensed for administration to infants and children. Population based studies of Hib disease from Australia, Chile, Finland, ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · May 1993
Featured Publication
To determine and compare the cost of Haemophilus influenzae type b (Hib) disease in Australia, Finland, Israel, Switzerland and the United Kingdom a collaborative study was undertaken. The incidence of Hib disease varies in these 5 countries from 34 to 58. ...
Full textLink to itemCite
Journal articleOncogene · May 1993
We have purified biologically active recombinant human fibroblast growth factor 5 (FGF-5) from Escherichia coli. In the presence of heparin, recombinant FGF-5 is as active as native growth factor, demonstrating that glycosylation does not significantly pot ...
Link to itemCite
Journal articleJ Clin Microbiol · July 1992
Outer membrane protein subtyping of 187 isolates of Haemophilus influenzae type b (Hib), isolated from children with invasive Hib disease in Victoria, Australia, showed that a single outer membrane protein subtype (1VA) was responsible for 83% of the infec ...
Full textLink to itemCite
Journal articleJ Infect Dis · June 1992
Featured Publication
Socioeconomic risk factors for primary invasive Haemophilus influenzae type b (Hib) disease include factors that increase exposure to Hib (day care attendance, presence of siblings, and crowded households) and factors that increase an individual's suscepti ...
Full textLink to itemCite
Journal articleAm J Public Health · June 1990
Featured Publication
Between 1984 and 1987 reported pertussis cases in North Carolina increased threefold. Pertussis immunization rates were examined for those years in three one-year cohorts drawn from a random selection of North Carolina birth records. The percentage of chil ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · April 1990
Invasive Haemophilus influenzae type b (HIB) infections occurring from 1985 to 1987 in children younger than 16 years of age living in the state of Victoria were reviewed. There were 547 cases which fulfilled the case definition, including 231 cases of men ...
Full textLink to itemCite
Journal articleJ Paediatr Child Health · February 1990
Seventy-six children (aged 17-19 months) received 10 micrograms of Haemophilus influenzae type b polyribosyl-ribitol phosphate (PRP) vaccine, diluted with either phosphate-buffered saline (PBS) or diphtheria-tetanus-pertussis (DTP) vaccine, in a single-bli ...
Full textLink to itemCite